Peptris Leverages AI to Accelerate Drug Candidate Discovery, Secures ₹70 Crore Series A Funding

Biotechnology

6 August 2026 at 4:01 am

Peptris Leverages AI to Accelerate Drug Candidate Discovery, Secures ₹70 Crore Series A Funding

HyperFast News

Summary

Peptris Technologies, a Bengaluru-based company founded in 2019, uses AI to accelerate preclinical drug discovery by generating novel molecular structures and predicting drug properties, recently raising ₹70 crore in Series A funding.

Select what you want to create

Turn this story into an image post, carousel, video, audio reel, blog, and more — all from HyperFast News.

FAQ

Newsroom FAQs

About the public HyperFast News news feed powered by NewsEngine.

Peptris Leverages AI to Accelerate Drug Candidate Discovery, Secures ₹70 Crore Series A Funding | HyperFast News